Bristol-Myers Squibb Co reports results for the quarter ended December 31 - Earnings Summary

• Bristol-Myers Squibb Co BMY.N reported quarterly adjusted earnings of $1.67​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of $1.70. The mean expectation of nineteen analysts for the quarter was for earnings of $1.46 per share. Wall Street expected results to range from $1.41 to $1.57 per share.

• Revenue rose 7.5% to $12.34 billion from a year ago; analysts expected $11.57 billion.

• Bristol-Myers Squibb Co's reported EPS for the quarter was 4 cents​.

• The company reported quarterly net income of $72 million.

• Bristol-Myers Squibb Co shares had risen by 5.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.8% in the last three months.​

• In the last 30 days, seven analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy," 17 "hold" and 2 "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "hold"

Wall Street's median 12-month price target for Bristol-Myers Squibb Co is $61.50

This summary was machine generated from LSEG data February 6 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)